Hong Kong scrambles for talent in battle for Nasdaq's biotech crown
HONG KONG (Reuters) - When Hong Kong unveiled plans last year to encourage biotech companies to list in the city by loosening listing rules, the financial industry and investors cheered.
from Reuters: Health News https://reut.rs/2FrCsNh
http://bit.ly/2zwRqiM